tiprankstipranks
Plandai Biotechnology Inc (PLPL)
OTHER OTC:PLPL
US Market

Plandai Biotechnology (PLPL) Price & Analysis

32 Followers

PLPL Stock Chart & Stats

<$0.01
$0.00(0.00%)
At close: 4:00 PM EST
<$0.01
$0.00(0.00%)

PLPL FAQ

What was Plandai Biotechnology Inc’s price range in the past 12 months?
Currently, no data Available
What is Plandai Biotechnology Inc’s market cap?
Plandai Biotechnology Inc’s market cap is $44.89K.
    When is Plandai Biotechnology Inc’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Plandai Biotechnology Inc’s earnings last quarter?
    Currently, no data Available
    Is Plandai Biotechnology Inc overvalued?
    According to Wall Street analysts Plandai Biotechnology Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Plandai Biotechnology Inc pay dividends?
      Plandai Biotechnology Inc does not currently pay dividends.
      What is Plandai Biotechnology Inc’s EPS estimate?
      Plandai Biotechnology Inc’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Plandai Biotechnology Inc have?
      Plandai Biotechnology Inc has 44,889,035,000 shares outstanding.
        What happened to Plandai Biotechnology Inc’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Plandai Biotechnology Inc?
        Currently, no hedge funds are holding shares in PLPL
        What is the TipRanks Smart Score and how is it calculated?
        Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

          Company Description

          Plandai Biotechnology Inc

          Plandaí Biotechnology, Inc. specializes in developing distinctive botanical extracts intended for the nutriceutical and pharmaceutical industries. A primary focus is the development of its Phytofare Catechin Complex, an extract originating from green tea cultivated at the Senteeko Tea Estate in Mpumalanga, South Africa. The company is also advancing its Phytofare citrus complex, a citrus-based extract, alongside extracts derived from tomato fruit, Artemisia, and cannabis. Beyond its biotechnological pursuits, Plandaí operates agricultural holdings in South Africa, where it produces and sells timber and various other farm products. The company's corporate base is in London, United Kingdom.
          Similar Stocks
          Company
          Price & Change
          Follow
          Silexion Therapeutics
          Real Messenger
          CERo Therapeutics Holdings
          Profusa
          Popular Stocks